Showing results (31-40 of 355) with videos related to
Sort By:
Pageof 36
Human Gene Therapy|January 13, 2012
Oncolytic measles virus encoding thyroidal sodium iodide symporter for squamous cell cancer of the head and neck radiovirotherapyHongtao Li, Kah-Whye Peng, Stephen J RussellJournal of Materials Chemistry. B|July 12, 2016
Photo-active collagen systems with controlled triple helix architectureGiuseppe Tronci, Stephen J Russell, David J WoodJournal of Virology|October 4, 2013
Characteristics of oncolytic vesicular stomatitis virus displaying tumor-targeting ligandsArun Ammayappan, Kah-Whye Peng, Stephen J RussellMolecular Therapy Oncolytics|August 25, 2016
Recombinant mumps virus as a cancer therapeutic agentArun Ammayappan, Stephen J Russell, Mark J FederspielMolecular Therapy : the Journal of the American Society of Gene Therapy|March 18, 2010
Systemic therapy of disseminated myeloma in passively immunized mice using measles virus-infected cell carriersChunsheng Liu, Stephen J Russell, Kah-Whye PengNature Reviews. Genetics|July 4, 2007
Engineering targeted viral vectors for gene therapyReinhard Waehler, Stephen J Russell, David T CurielVirology|October 31, 2003
Avian leukosis virus is a versatile eukaryotic platform for polypeptide displayPranay D Khare, Stephen J Russell, Mark J FederspielExperimental Hematology|September 27, 2013
Oncolytic vesicular stomatitis virus and bortezomib are antagonistic against myeloma cells in vitro but have additive anti-myeloma activity in vivoDanielle N Yarde, Rebecca A Nace, Stephen J RussellMolecular Therapy : the Journal of the American Society of Gene Therapy|April 21, 2011
Myeloma xenograft destruction by a nonviral vector delivering oncolytic infectious nucleic acidElizabeth M Hadac, Elizabeth J Kelly, Stephen J RussellCurrent Gene Therapy|January 24, 2012
The sodium iodide symporter (NIS) as an imaging reporter for gene, viral, and cell-based therapiesAlan R Penheiter, Stephen J Russell, Stephanie K CarlsonPageof 36